Fedovapagon is a selective vasopressin V2 receptor agonist that functions as an antidiuretic agent by stimulating receptors in the renal collecting ducts to promote water reabsorption. It is primarily… Read more
Fedovapagon is a selective vasopressin V2 receptor agonist that functions as an antidiuretic agent by stimulating receptors in the renal collecting ducts to promote water reabsorption. It is primarily developed for the treatment of nocturia, a condition characterized by excessive nighttime urination. This category offers essential analytical tools required for the rigorous evaluation and quality assurance of this compound, including reference standards of the active pharmaceutical ingredient alongside its related substances, such as both pharmacopeial and non-pharmacopeial impurities. Additionally, stable isotope labelled compounds, such as Fedovapagon-d6, are provided for pharmaceutical laboratories conducting precise quantitative analysis. These high-purity materials are vital for accurate impurity profiling, assay validation, and routine quality control testing, ensuring consistent and reliable results throughout the analytical development and regulatory compliance process.